Luca Cicalese, MD, FACS

Projects

Projects per year 2012 2012 2013 2016

• 2 Finished

Projects per year

Search results

• Finished

  Protocol No. ARQ197-A-U303 entitled "A Phase 3, Randomized, Double-Blind Study of Tivantinib (ARQ 197) in Subjects with MET Diagnostic-High Inoperable Hepatocellular Carcinoma (HCC) Treated with One Prior Systemic Therapy"

  Cicalese, L. (PI)

  Daiichi-Sankyo

  3/22/13 → 5/1/16

  Project: Research project

• Protocol No.: IM103076; Evaluating Nulojix Long Term Safety in Transplant, ENLIST Study: 203387

  Cicalese, L. (PI)

  Bristol-Myers Squibb Company

  6/13/12 → 6/12/16

  Project: Research project